Physiomics Share Discussion Threads

[share14] 01/10/2023 23:59

Probably still be claiming they have 800k cash and 2 years runway in January.

[davevt] 01/10/2023 17:32

Laura is now trying to spin a 1p placing as a good thing as they now have more cash 🤣

[share14] 30/9/2023 19:03

Dear oh dear

[davevt] 30/9/2023 18:00

It's funny how pyc put the TM suffix next to whenever they mention Virtual Tumour.

They don't have this trademark, it was withdrawn in 2019.

[share14] 29/9/2023 18:52

More money than sense. 80k in at 2.7 following a 1p raise.

[davevt] 29/9/2023 17:16

Think of the person that bought 80k worth at 2.7...

'Follow the money' the clowns said..

I would suggest not following someone who's £80k is now worth £48k in one week, unless you like following your money down the toilet..

[davevt] 29/9/2023 13:46

Notice Laura never addresses any negative comments made to him. same as when he was Riddler.

[share14] 29/9/2023 12:53

"Physiomics' strategy is to grow its consulting business while actively investigating other possible applications of our core modelling and simulation capabilities such as in personalised medicine."

It's a consultancy, no product. It's been a consultancy with no product for a long time. I don't know why so many people come to these forums and don't understand this.

There is no "Killer AI app", it has as much potential to build one as any other company that has no track record of building killer AI apps.

People should at least base the risk reward of the investment off these simple facts rather than continually cheerleading the idea that it's going to land some monster profit in the near future. If it was that easy it would have done it over a decade ago.

As a consultancy it's people heavy and now significantly loss making and I don't think that's good management. But we all have different views, and at least if people price the risk based on facts nobody can argue with it.

But there's so much disinformation floating around these forums that it rarely happens.I have no idea where this 500k euro from Merck idea came from Laura either, just more of the same old bandy about a few figures that make the company look good. "2 years cash runway, 50k cash burn, imminent news." Time and time again these things turn out to be false. It's ridiculous. How anyone can do this day after day for years and get away with it is beyond me. And how people can be so immoral is beyond me too.

The usual "going to 5p next week" crowd have come and gone again, and now the dust has settled and the reality has kicked in they;'re nowhere to be found. No doubt a few have been burned in the process. It's a cycle that's been repeating for years.

Will it suddenly pull a rabbit out of the hat? I don't know but I wouldn't bet on it. People that are need to take the track record of the company into account, note the losses, and proceed with caution and the knowledge that they may lose all their money.

[davevt] 29/9/2023 09:21

Sienna on LSE...'Someone posted on telegram that the A I side could take about 5 years'

Pyc have never claimed they are doing anything A.I related with their modelling. Anywhere.

The only mention of A.I being mentioned was collating data for the web application. That's a software thing for a web application...nothing to do with their modelling.

Chinese whispers and all that.

[davevt] 28/9/2023 18:21

Because they don't research. Correct, pyc is just a tiny group of computer bods in a rented office space in the Magdelen Centre.

Why does Laura keep saying there is a £million of projects due?

The rns clearly states...'Order pipeline of potential projects that could start in the current financial year ending 30 June 2024 of over £1m.'

So basically, they have none of these potential leads confirmed, otherwise they wouldn't be saying 'potential' or 'could start'.

Who remembers past rns where 'we are in talks with 20 prospective clients'......and what do they get? Lucky to get one.

And who cares what the revenues are...every time revenues increase, so do the losses.

Basically, meaningless.

[share14] 28/9/2023 17:25

Pharma's make drugs which sell to billions of people repeatedly each year which is a high margin business model with high initial costs

PYC has a handful of clients over 20 years of existence which it sells its services to for low revenue streams which it can't make a profit on

Why are you classifying this as a pharma? It's a tiny consultancy with no apparent direction

[parob] 28/9/2023 11:07

Possibly some cash moving into APTA which is breaking 1.5p

[share14] 28/9/2023 09:57

They're still hiring and sending people off to conferences.

Confidence or mismanagement? I know what my money would be on.

[7rademark] 28/9/2023 09:51

I actually think it's worth a punt at these levels, I don't invest in pharmaceuticals usually so I'll hold off for now but it's on the watch list.

[share14] 28/9/2023 09:45

They are terrible results, which is why the share price is where it is.

A couple of years back they talked about record revenues, strong pipelines, etc. etc. They've done c600k revenue and c500k loss this year

Nothing they say has any credibility to the wider market, even II's wouldn't pay more than a penny for this stock. It's only a few naive or unsavoury people around these forums who have no credibility that seem to think they have any credibility.

[davevt] 28/9/2023 09:16

So, as expected, pyc continue to do less turnover than your local pub, and zero profit and huge losses.

If the company wasn't d.floated it would have gone bust 15 years ago

[davevt] 28/9/2023 09:15

Tees..

' at this point a single contract should be £1m+. Not the value of the whole damn pipeline?'

Who is gonna pay 1m to have dosing predicted for a drug? 🤣🤣 pyc charge €35k for this service,

[7rademark] 28/9/2023 08:27

I don't think these earnings are terrible at all, the negatives are well explained and the forward looking statement is clear. The last quarter has seen contract wins and if these continue to the stated 1m then pyc will rerate from these lowly figures. Blue later today imo.

[iammrweald] 28/9/2023 08:09

Any thoughts gizmo??

[tees maar khan] 28/9/2023 08:05

Down we go!

TMK

[tees maar khan] 28/9/2023 08:04

Awful leadership and poor company. Millen will keep repeating the same mistakes.

At this point a single contract should be £1m+. Not the value of the whole damn pipeline?

VAL 201 remains on the back-burner as well. On top of that they're still in discussions with DoseMeRx. Bravo!

What a complete waste of time and potential.

TMK

[bmwman3] 28/9/2023 07:47

Don't forget AFTER these results Merck came back on board and spend €500k+ annually ( main reason for the slip to £609k rev) and from today's RNS For the first time ever, the Company has felt in a position to quantify the value of its pipeline of potential new contracts that could start in the current financial year which remains at over £1m despite four opportunities having been converted into signed projects during August. This was facilitated through the implementation of a formal CRM process to manage and track opportunities

[bmwman3] 28/9/2023 07:33

BTW not invested here just sharing thoughts